This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

New California compounding pharmacy rules pass early trade secret test

By Nick Robertson ( January 27, 2026, 21:57 GMT | Insight) -- A California judge has dismissed claims that new state compounding pharmacy disclosure rules constitute a regulatory taking of trade secrets. Monday’s decision is a poor sign for compounders hoping to fight back against state disclosure requirements, after the Ninth Circuit overturned an Oregon decision in the industry’s favor last year.A recent California rule change requiring compounding pharmacies to disclose their ingredient manufacturers does not constitute a forced disclosure of trade secrets, a federal judge there ruled Monday. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections